Pan-cancer proteogenomics connects oncogenic drivers to functional states
2023 · Cell · 91 citations
https://doi.org/10.1016/j.cell.2023.07.014
K
Kathleen J. Imbach
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
16
Papers
216
Citations
6
h-index
5
i10-index
Kathleen J. Imbach is an academic researcher from Josep Carreras Leukaemia Research Institute. The author has contributed to research in topics: Cancer Genomics and Diagnostics & CAR-T cell therapy research & Epigenetics and DNA Methylation. The author has an h-index of 6, co-authored 14 publications.
ORCID: 0000-0002-3861-7845Papers by this author
worksMulti-scale signaling and tumor evolution in high-grade gliomas
2024 · Cancer Cell · 44 citations
https://doi.org/10.1016/j.ccell.2024.06.004
Cis inhibition of NOTCH1 through JAGGED1 sustains embryonic hematopoietic stem cell fate
2024 · Nature Communications · 25 citations
https://doi.org/10.1038/s41467-024-45716-y
B-cell acute lymphoblastic leukemia promotes an immune suppressive microenvironment that can be overcome by IL-12
2022 · Scientific Reports · 22 citations
https://doi.org/10.1038/s41598-022-16152-z
Precision proteogenomics reveals pan-cancer impact of germline variants
2025 · Cell · 4 citations
https://doi.org/10.1016/j.cell.2025.03.026
Radical fringe facilitates NOTCH1 and JAG1 <i>cis</i> interactions to sustain Hematopoietic stem cell fate
2023 · bioRxiv (Cold Spring Harbor Laboratory) · 0 citations
https://doi.org/10.1101/2023.04.19.537430
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat